INFLIXIMAB AS THIRD-LINE THERAPY FOR DIFFICULT-TO-TREAT AUTOIMMUNE HEPATITIS

被引：0
|
作者：
Weiler-Normann, Christina [1 ]
Wiegard, Christiane C. [1 ]
Glaubke, Claudia [1 ]
Quaas, Alexander [2 ]
Schramm, Christoph [1 ]
Lahse, Ansgar W. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Med Klin 1, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Dept Pathol, Hamburg, Germany
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1672
引用
收藏
页码：1118A / 1118A
页数：1
相关论文
共 50 条
  • [31] Third-line therapy for metastatic colorectal cancer
    Gundgaard, M. G.
    Soerensen, J. B.
    Ehrnrooth, E.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (01) : 1 - 13
  • [32] Infliximab as rescue therapy in paediatric autoimmune hepatitis
    Rajanayagam, Jeremy
    Lewindon, Peter J.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 59 (04) : 908 - 909
  • [33] Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan
    Kumada, Hiromitsu
    Sato, Ken
    Takehara, Tetsuo
    Nakamuta, Makoto
    Ishigami, Masatoshi
    Chayama, Kazuaki
    Toyota, Joji
    Suzuki, Fumitaka
    Nakayasu, Yoshiyuki
    Ochi, Miyoko
    Yamada, Ichimaro
    Okanoue, Takeshi
    [J]. HEPATOLOGY RESEARCH, 2015, 45 (07) : 745 - 754
  • [34] The hepatitis C revolution part 2: difficult-to-treat groups and experimental approaches
    Thiagarajan, Prarthana
    Ryder, Stephen D.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (06) : 572 - 575
  • [35] Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients
    Minguez, Carlos
    Garcia-Deltoro, Miguel
    Flores, Juan
    Galindo, Maria-Jose
    Montero, Marta
    Reus, Sergio
    Carmena, Jorge
    Masia, Mar
    Amador, Concepcion
    Ortega, Enrique
    [J]. AIDS, 2018, 32 (03) : 337 - 346
  • [36] Speech therapy in the management of difficult-to-treat chronic cough - preliminary results
    Dabrowska, Marta
    Grabczak, Elibieta M.
    Rojek, Dorota
    Lobacz, Anna
    Klimowicz, Karolina
    Truba, Olga
    Rybka, Aleksandra
    Krzeski, Antoni
    Krenke, Rafel
    [J]. ADVANCES IN RESPIRATORY MEDICINE, 2018, 86 (06) : 268 - 274
  • [37] The response to combination therapy treatment regimens in severe/difficult-to-treat asthma
    Campbell, J. D.
    Borish, L.
    Haselkorn, T.
    Rasouliyan, L.
    Lee, J. H.
    Wenzel, S. E.
    Sullivan, S. D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (05) : 1237 - 1242
  • [38] Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy
    Louhaichi, Sabrine
    Hamdi, Besma
    Khalfallah, Ikbel
    Akkad, Alaa
    Ammar, Jamel
    Berraies, Anissa
    Hamzaoui, Agnes
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [39] Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review
    Uyttebroek, Saartje
    Chen, Baixing
    Onsea, Jolien
    Ruythooren, Fred
    Debaveye, Yves
    Devolder, David
    Spriet, Isabel
    Depypere, Melissa
    Wagemans, Jeroen
    Lavigne, Rob
    Pirnay, Jean-Paul
    Merabishvili, Maya
    De Munter, Paul
    Peetermans, Willy E.
    Dupont, Lieven
    Van Gerven, Laura
    Metsemakers, Willem-Jan
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (08): : E208 - E220
  • [40] Omalizumab: an effective and rapidly acting therapy in difficult-to-treat chronic urticaria
    Ohanyan, T.
    Metz, M.
    Church, M.
    Maurer, M.
    [J]. ALLERGY, 2013, 68 : 260 - 260
12345